Teva Pharma (TEVA) volatility increases on Mylan (MYL) granted FDA approval of Copaxone

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to Teva Pharma (TEVA) volatility increases on Mylan (MYL) granted FDA approval of Copaxone

Teva Pharma (TEVA) PT Lowered to $15 at Morgan Stanley

October 5, 2017 8:58 AM EDT

Morgan Stanley lowered its price target on Teva Pharma (NYSE: TEVA) to $15.00 (from $16.00) while maintaining a Underweight rating.

... More